Michigan's changing demographics--what they mean to health care

First-in-human phase I study to evaluate safety, tolerability, pharmacokinetics, pharmacodynamics, immunogenicity, and antitumor activity of PF-07209960 in patients with advanced or metastatic solid tumors.

ESMO open·2025

PF-06952229, a selective TGF-β-R1 inhibitor: preclinical development and a first-in-human, phase I, dose-escalation study in advanced solid tumors.

ESMO open·2024

Effect of rifampin on the pharmacokinetics, safety and tolerability of navitoclax (ABT-263), a dual inhibitor of Bcl-2 and Bcl-XL , in patients with cancer.

Journal of clinical pharmacy and therapeutics·2014

A phase I study evaluating the effect of CDHP as a component of S-1 on the pharmacokinetics of 5-fluorouracil.

Anticancer research·2011

A phase I study to determine the safety, pharmacokinetics and pharmacodynamics of a dual VEGFR and FGFR inhibitor, brivanib, in patients with advanced or metastatic solid tumors.

Annals of oncology : official journal of the European Society for Medical Oncology·2010

Low-dose trimetrexate glucuronate and protracted 5-fluorouracil infusion in previously untreated patients with advanced pancreatic cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2002

Healthy communities. Our focus for the future.

Michigan hospitals·1995

Putting patients first.

Michigan hospitals·1995

Dispersal kernels regulate environmental, biotic, and stochastic effects on the maintenance of metacommunity diversity.

Ecology·2026

What drives you to relocate your home? Investigating preferences and residential mismatching of recent (prior to COVID and during-after COVID) movers in the Greater Toronto Area.

Environment and planning. B, urban analytics and city science·2026

Early-life residential mobility as a social determinant of mood disorder risk: A nationwide longitudinal cohort study in South Korea.

SSM - population health·2026

Burden of Tension-Type Headache Among Older Adults in the Middle East and North Africa Region, 1990-2023.

Health science reports·2026

Exon-skipping therapies for DMD in Kazakhstan: Progress and challenges.

Journal of neuromuscular diseases·2026

From work-unit member to social individual: Retirement transition patterns, leisure reconfiguration, and depressive symptom trajectories in China.

Medicine·2026

Related Experiment Videos

Michigan's changing demographics--what they mean to health care

Related Concept Videos

First-in-human phase I study to evaluate safety, tolerability, pharmacokinetics, pharmacodynamics, immunogenicity, and antitumor activity of PF-07209960 in patients with advanced or metastatic solid tumors.

PF-06952229, a selective TGF-β-R1 inhibitor: preclinical development and a first-in-human, phase I, dose-escalation study in advanced solid tumors.

Effect of rifampin on the pharmacokinetics, safety and tolerability of navitoclax (ABT-263), a dual inhibitor of Bcl-2 and Bcl-XL , in patients with cancer.

A phase I study evaluating the effect of CDHP as a component of S-1 on the pharmacokinetics of 5-fluorouracil.

A phase I study to determine the safety, pharmacokinetics and pharmacodynamics of a dual VEGFR and FGFR inhibitor, brivanib, in patients with advanced or metastatic solid tumors.

Low-dose trimetrexate glucuronate and protracted 5-fluorouracil infusion in previously untreated patients with advanced pancreatic cancer.

Healthy communities. Our focus for the future.

Putting patients first.

Dispersal kernels regulate environmental, biotic, and stochastic effects on the maintenance of metacommunity diversity.

What drives you to relocate your home? Investigating preferences and residential mismatching of recent (prior to COVID and during-after COVID) movers in the Greater Toronto Area.

Early-life residential mobility as a social determinant of mood disorder risk: A nationwide longitudinal cohort study in South Korea.

Burden of Tension-Type Headache Among Older Adults in the Middle East and North Africa Region, 1990-2023.

Exon-skipping therapies for DMD in Kazakhstan: Progress and challenges.

From work-unit member to social individual: Retirement transition patterns, leisure reconfiguration, and depressive symptom trajectories in China.

Related Experiment Videos

Michigan's changing demographics--what they mean to health care

Related Concept Videos

Related Articles